Iroko Pharmaceuticals Inc., of Philadelphia, said the Republic of Lebanon Ministry of Public Health approved Zorvolex (diclofenac), a nonsteroidal anti-inflammatory drug, to treat mild-to-moderate acute pain and osteoarthritis pain. The drug is approved in the U.S. in the same indications.